Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia–reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway

•The FAAH and MAGL enzymes that degrade AEA and 2-AG are expressed in the kidney.•Endocannabinoid substances AEA and 2-AG level are associated with IR damage.•Inhibition of FAAH and MAGL reduced inflammation caused by renal ischemia reperfusion injury.•FAAH and MAGL inhibition also reduced kidney dy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2023-01, Vol.114, p.109586-109586, Article 109586
Hauptverfasser: Çakır, Murat, Aydın, Ali, Tekin, Suat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109586
container_issue
container_start_page 109586
container_title International immunopharmacology
container_volume 114
creator Çakır, Murat
Aydın, Ali
Tekin, Suat
description •The FAAH and MAGL enzymes that degrade AEA and 2-AG are expressed in the kidney.•Endocannabinoid substances AEA and 2-AG level are associated with IR damage.•Inhibition of FAAH and MAGL reduced inflammation caused by renal ischemia reperfusion injury.•FAAH and MAGL inhibition also reduced kidney dysfunction and apoptosis. Arachidonoyl ethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) are the most studies endocannabinoids. AEA and 2-AG are degraded by fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) enzymes, respectively. FAAH and MAGL enzymes are widely expressed in many tissues, including kidney. Recent works have depicted that AEA and 2-AG levels are associated with ischemia–reperfusion (IR) injury. In this study, we investigated the effects of MAGL inhibitor KML29 and FAAH inhibitor URB597 against kidney IR injury. The kidneys of the rats underwent ischemia for 45 min and then reperfusion for 24 h. KML29 and URB597 were administered intraperitoneally with kidney IR to two different treatment groups. IR application increased serum blood urea nitrogen (BUN), creatinine (Cre), interleukin-18 (IL-18), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) levels, while these parameters were decreased following KML29 and URB597 administration. KML29 and URB597 administration also reduced the increased toll-like receptor-4 (TRL-4), phosphorylated-NF-κB, phosphorylated-IκB-α, tumor necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β), interleukin-6 (IL-6), caspase-3 levels and histopathological damage in kidney tissue. Our results reveal that MAGL inhibitor KML29 and FAAH inhibitor URB597 have a protective effect on kidney IR injury by preventing apoptosis and inflammation. Inhibition of MAGL and FAAH may be a new therapeutic strategy to prevent kidney IR injury.
doi_str_mv 10.1016/j.intimp.2022.109586
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2769997032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1567576922010712</els_id><sourcerecordid>2769997032</sourcerecordid><originalsourceid>FETCH-LOGICAL-c292t-998e77e28ea0676ccee0e37674027468f57092975ddd960cc1f80b8d3b0943ee3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEoqXwBgh5ySZTx7k43iDRqhTEIBCia8tjnzBn6tjBdgZl13fgsXgLngSPpiCxYeWj39-5_kXxvKKrilbd-W6FLuE4rRhlLEui7bsHxWnV876sOG0f5rjteNnyTpwUT2LcUZr1pnpcnNQdpzTrp8XPT8En0An3QGAYckT8QAaV0kKURkPUiAbIdjHBWxWBoNviBpMP5ObzRSs4Uc6Q0Tuv9GK_2kVDBonF6V_4_Yc1E8Q7EsApSzDqLYyoft39CDBBGOaI-RPdbg4L2aMiyVtbWryFnKFhOtRozt2sLaiQ59NZKG_VNClyQSaVtt_V8rR4NCgb4dn9e1bcvLn6cvm2XH-8fnf5el1qJlgqheiBc2A9KNrxTmsACjXveEMZb7p-aDkVTPDWGCM6qnU19HTTm3pDRVMD1GfFy2PdKfhvM8Qkx7wPWKsc-DlKli8rBKc1y2hzRHXwMQYY5BRwVGGRFZUHG-VOHm2UBxvl0cac9uK-w7wZwfxN-uNbBl4dAch77hGCjBrBaTCYz5Wk8fj_Dr8BsZS1Ng</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2769997032</pqid></control><display><type>article</type><title>Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia–reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Çakır, Murat ; Aydın, Ali ; Tekin, Suat</creator><creatorcontrib>Çakır, Murat ; Aydın, Ali ; Tekin, Suat</creatorcontrib><description>•The FAAH and MAGL enzymes that degrade AEA and 2-AG are expressed in the kidney.•Endocannabinoid substances AEA and 2-AG level are associated with IR damage.•Inhibition of FAAH and MAGL reduced inflammation caused by renal ischemia reperfusion injury.•FAAH and MAGL inhibition also reduced kidney dysfunction and apoptosis. Arachidonoyl ethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) are the most studies endocannabinoids. AEA and 2-AG are degraded by fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) enzymes, respectively. FAAH and MAGL enzymes are widely expressed in many tissues, including kidney. Recent works have depicted that AEA and 2-AG levels are associated with ischemia–reperfusion (IR) injury. In this study, we investigated the effects of MAGL inhibitor KML29 and FAAH inhibitor URB597 against kidney IR injury. The kidneys of the rats underwent ischemia for 45 min and then reperfusion for 24 h. KML29 and URB597 were administered intraperitoneally with kidney IR to two different treatment groups. IR application increased serum blood urea nitrogen (BUN), creatinine (Cre), interleukin-18 (IL-18), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) levels, while these parameters were decreased following KML29 and URB597 administration. KML29 and URB597 administration also reduced the increased toll-like receptor-4 (TRL-4), phosphorylated-NF-κB, phosphorylated-IκB-α, tumor necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β), interleukin-6 (IL-6), caspase-3 levels and histopathological damage in kidney tissue. Our results reveal that MAGL inhibitor KML29 and FAAH inhibitor URB597 have a protective effect on kidney IR injury by preventing apoptosis and inflammation. Inhibition of MAGL and FAAH may be a new therapeutic strategy to prevent kidney IR injury.</description><identifier>ISSN: 1567-5769</identifier><identifier>EISSN: 1878-1705</identifier><identifier>DOI: 10.1016/j.intimp.2022.109586</identifier><identifier>PMID: 36700769</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Amidohydrolases ; Animals ; Endocannabinoids - metabolism ; Endocannabinoids - therapeutic use ; Fatty acid amide hydrolase ; Ischemia–reperfusion injury ; Kidney ; Kidney - metabolism ; KML29 ; Monoacylglycerol lipase ; Monoacylglycerol Lipases - metabolism ; Monoglycerides ; NF-kappa B ; Rats ; Reperfusion Injury - drug therapy ; Toll-Like Receptor 4 ; URB597</subject><ispartof>International immunopharmacology, 2023-01, Vol.114, p.109586-109586, Article 109586</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c292t-998e77e28ea0676ccee0e37674027468f57092975ddd960cc1f80b8d3b0943ee3</citedby><cites>FETCH-LOGICAL-c292t-998e77e28ea0676ccee0e37674027468f57092975ddd960cc1f80b8d3b0943ee3</cites><orcidid>0000-0002-2066-829X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.intimp.2022.109586$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36700769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Çakır, Murat</creatorcontrib><creatorcontrib>Aydın, Ali</creatorcontrib><creatorcontrib>Tekin, Suat</creatorcontrib><title>Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia–reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway</title><title>International immunopharmacology</title><addtitle>Int Immunopharmacol</addtitle><description>•The FAAH and MAGL enzymes that degrade AEA and 2-AG are expressed in the kidney.•Endocannabinoid substances AEA and 2-AG level are associated with IR damage.•Inhibition of FAAH and MAGL reduced inflammation caused by renal ischemia reperfusion injury.•FAAH and MAGL inhibition also reduced kidney dysfunction and apoptosis. Arachidonoyl ethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) are the most studies endocannabinoids. AEA and 2-AG are degraded by fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) enzymes, respectively. FAAH and MAGL enzymes are widely expressed in many tissues, including kidney. Recent works have depicted that AEA and 2-AG levels are associated with ischemia–reperfusion (IR) injury. In this study, we investigated the effects of MAGL inhibitor KML29 and FAAH inhibitor URB597 against kidney IR injury. The kidneys of the rats underwent ischemia for 45 min and then reperfusion for 24 h. KML29 and URB597 were administered intraperitoneally with kidney IR to two different treatment groups. IR application increased serum blood urea nitrogen (BUN), creatinine (Cre), interleukin-18 (IL-18), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) levels, while these parameters were decreased following KML29 and URB597 administration. KML29 and URB597 administration also reduced the increased toll-like receptor-4 (TRL-4), phosphorylated-NF-κB, phosphorylated-IκB-α, tumor necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β), interleukin-6 (IL-6), caspase-3 levels and histopathological damage in kidney tissue. Our results reveal that MAGL inhibitor KML29 and FAAH inhibitor URB597 have a protective effect on kidney IR injury by preventing apoptosis and inflammation. Inhibition of MAGL and FAAH may be a new therapeutic strategy to prevent kidney IR injury.</description><subject>Amidohydrolases</subject><subject>Animals</subject><subject>Endocannabinoids - metabolism</subject><subject>Endocannabinoids - therapeutic use</subject><subject>Fatty acid amide hydrolase</subject><subject>Ischemia–reperfusion injury</subject><subject>Kidney</subject><subject>Kidney - metabolism</subject><subject>KML29</subject><subject>Monoacylglycerol lipase</subject><subject>Monoacylglycerol Lipases - metabolism</subject><subject>Monoglycerides</subject><subject>NF-kappa B</subject><subject>Rats</subject><subject>Reperfusion Injury - drug therapy</subject><subject>Toll-Like Receptor 4</subject><subject>URB597</subject><issn>1567-5769</issn><issn>1878-1705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhiMEoqXwBgh5ySZTx7k43iDRqhTEIBCia8tjnzBn6tjBdgZl13fgsXgLngSPpiCxYeWj39-5_kXxvKKrilbd-W6FLuE4rRhlLEui7bsHxWnV876sOG0f5rjteNnyTpwUT2LcUZr1pnpcnNQdpzTrp8XPT8En0An3QGAYckT8QAaV0kKURkPUiAbIdjHBWxWBoNviBpMP5ObzRSs4Uc6Q0Tuv9GK_2kVDBonF6V_4_Yc1E8Q7EsApSzDqLYyoft39CDBBGOaI-RPdbg4L2aMiyVtbWryFnKFhOtRozt2sLaiQ59NZKG_VNClyQSaVtt_V8rR4NCgb4dn9e1bcvLn6cvm2XH-8fnf5el1qJlgqheiBc2A9KNrxTmsACjXveEMZb7p-aDkVTPDWGCM6qnU19HTTm3pDRVMD1GfFy2PdKfhvM8Qkx7wPWKsc-DlKli8rBKc1y2hzRHXwMQYY5BRwVGGRFZUHG-VOHm2UBxvl0cac9uK-w7wZwfxN-uNbBl4dAch77hGCjBrBaTCYz5Wk8fj_Dr8BsZS1Ng</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Çakır, Murat</creator><creator>Aydın, Ali</creator><creator>Tekin, Suat</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2066-829X</orcidid></search><sort><creationdate>202301</creationdate><title>Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia–reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway</title><author>Çakır, Murat ; Aydın, Ali ; Tekin, Suat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c292t-998e77e28ea0676ccee0e37674027468f57092975ddd960cc1f80b8d3b0943ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Amidohydrolases</topic><topic>Animals</topic><topic>Endocannabinoids - metabolism</topic><topic>Endocannabinoids - therapeutic use</topic><topic>Fatty acid amide hydrolase</topic><topic>Ischemia–reperfusion injury</topic><topic>Kidney</topic><topic>Kidney - metabolism</topic><topic>KML29</topic><topic>Monoacylglycerol lipase</topic><topic>Monoacylglycerol Lipases - metabolism</topic><topic>Monoglycerides</topic><topic>NF-kappa B</topic><topic>Rats</topic><topic>Reperfusion Injury - drug therapy</topic><topic>Toll-Like Receptor 4</topic><topic>URB597</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Çakır, Murat</creatorcontrib><creatorcontrib>Aydın, Ali</creatorcontrib><creatorcontrib>Tekin, Suat</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Çakır, Murat</au><au>Aydın, Ali</au><au>Tekin, Suat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia–reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway</atitle><jtitle>International immunopharmacology</jtitle><addtitle>Int Immunopharmacol</addtitle><date>2023-01</date><risdate>2023</risdate><volume>114</volume><spage>109586</spage><epage>109586</epage><pages>109586-109586</pages><artnum>109586</artnum><issn>1567-5769</issn><eissn>1878-1705</eissn><abstract>•The FAAH and MAGL enzymes that degrade AEA and 2-AG are expressed in the kidney.•Endocannabinoid substances AEA and 2-AG level are associated with IR damage.•Inhibition of FAAH and MAGL reduced inflammation caused by renal ischemia reperfusion injury.•FAAH and MAGL inhibition also reduced kidney dysfunction and apoptosis. Arachidonoyl ethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) are the most studies endocannabinoids. AEA and 2-AG are degraded by fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) enzymes, respectively. FAAH and MAGL enzymes are widely expressed in many tissues, including kidney. Recent works have depicted that AEA and 2-AG levels are associated with ischemia–reperfusion (IR) injury. In this study, we investigated the effects of MAGL inhibitor KML29 and FAAH inhibitor URB597 against kidney IR injury. The kidneys of the rats underwent ischemia for 45 min and then reperfusion for 24 h. KML29 and URB597 were administered intraperitoneally with kidney IR to two different treatment groups. IR application increased serum blood urea nitrogen (BUN), creatinine (Cre), interleukin-18 (IL-18), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) levels, while these parameters were decreased following KML29 and URB597 administration. KML29 and URB597 administration also reduced the increased toll-like receptor-4 (TRL-4), phosphorylated-NF-κB, phosphorylated-IκB-α, tumor necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β), interleukin-6 (IL-6), caspase-3 levels and histopathological damage in kidney tissue. Our results reveal that MAGL inhibitor KML29 and FAAH inhibitor URB597 have a protective effect on kidney IR injury by preventing apoptosis and inflammation. Inhibition of MAGL and FAAH may be a new therapeutic strategy to prevent kidney IR injury.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36700769</pmid><doi>10.1016/j.intimp.2022.109586</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-2066-829X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1567-5769
ispartof International immunopharmacology, 2023-01, Vol.114, p.109586-109586, Article 109586
issn 1567-5769
1878-1705
language eng
recordid cdi_proquest_miscellaneous_2769997032
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Amidohydrolases
Animals
Endocannabinoids - metabolism
Endocannabinoids - therapeutic use
Fatty acid amide hydrolase
Ischemia–reperfusion injury
Kidney
Kidney - metabolism
KML29
Monoacylglycerol lipase
Monoacylglycerol Lipases - metabolism
Monoglycerides
NF-kappa B
Rats
Reperfusion Injury - drug therapy
Toll-Like Receptor 4
URB597
title Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia–reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T07%3A28%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protective%20effect%20of%20fatty%20acid%20amide%20hydrolase%20inhibitor%20URB597%20and%20monoacylglycerol%20lipase%20inhibitor%20KML29%20on%20renal%20ischemia%E2%80%93reperfusion%20injury%20via%20toll-like%20receptor%204/nuclear%20factor-kappa%20B%20pathway&rft.jtitle=International%20immunopharmacology&rft.au=%C3%87ak%C4%B1r,%20Murat&rft.date=2023-01&rft.volume=114&rft.spage=109586&rft.epage=109586&rft.pages=109586-109586&rft.artnum=109586&rft.issn=1567-5769&rft.eissn=1878-1705&rft_id=info:doi/10.1016/j.intimp.2022.109586&rft_dat=%3Cproquest_cross%3E2769997032%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2769997032&rft_id=info:pmid/36700769&rft_els_id=S1567576922010712&rfr_iscdi=true